ziprasidone has been researched along with Death, Sudden, Cardiac in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Price, LH | 1 |
| D'Agostino, RB; Eng, SM; Faich, G; Kane, JM; Reynolds, RF; Ruskin, J; Strom, BL | 1 |
| Stroup, TS | 1 |
| Camm, JA; Eng, S; Geier, JL; Karayal, ON; Keane, M; Kolluri, S; Kremer, CM; Lewis, M; Reynolds, R; Strom, BL | 1 |
| Taylor, DM | 1 |
2 trial(s) available for ziprasidone and Death, Sudden, Cardiac
| Article | Year |
|---|---|
Comparative mortality associated with ziprasidone and olanzapine in real-world use among 18,154 patients with schizophrenia: The Ziprasidone Observational Study of Cardiac Outcomes (ZODIAC).
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Cause of Death; Cross-Sectional Studies; Death, Sudden, Cardiac; Diabetic Ketoacidosis; Female; Hospitalization; Humans; Incidence; Kaplan-Meier Estimate; Long QT Syndrome; Male; Middle Aged; Myocardial Infarction; Olanzapine; Piperazines; Product Surveillance, Postmarketing; Prospective Studies; Risk; Schizophrenia; Suicide; Thiazoles | 2011 |
Methodological challenges in the coding and adjudication of sudden deaths in a large simple trial with observational follow-up: the ziprasidone observational study of cardiac outcomes (ZODIAC).
Topics: Antipsychotic Agents; Benzodiazepines; Cause of Death; Clinical Coding; Death, Sudden; Death, Sudden, Cardiac; Endpoint Determination; Follow-Up Studies; Heart; Humans; Incidence; International Classification of Diseases; Olanzapine; Piperazines; Product Surveillance, Postmarketing; Research Design; Risk; Schizophrenia; Sensitivity and Specificity; Surveys and Questionnaires; Thiazoles; Time Factors; United States; United States Food and Drug Administration | 2011 |
3 other study(ies) available for ziprasidone and Death, Sudden, Cardiac
| Article | Year |
|---|---|
Atypical antipsychotic drugs and the risk of sudden cardiac death.
Topics: Antipsychotic Agents; Aripiprazole; Death, Sudden, Cardiac; Dose-Response Relationship, Drug; Humans; Mental Disorders; Piperazines; Quinolones; Risk; Thiazoles | 2009 |
What can large simple trials do for psychiatry?
Topics: Adverse Drug Reaction Reporting Systems; Antipsychotic Agents; Death, Sudden, Cardiac; Humans; Long QT Syndrome; Multicenter Studies as Topic; Piperazines; Product Surveillance, Postmarketing; Randomized Controlled Trials as Topic; Risk Factors; Schizophrenia; Thiazoles | 2011 |
Prolongation of QTc interval and antipsychotics.
Topics: Antipsychotic Agents; Death, Sudden, Cardiac; Drug Administration Schedule; Drug Labeling; Drug Monitoring; Haloperidol; Humans; Long QT Syndrome; Piperazines; Risperidone; Thiazoles | 2002 |